(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEURONOX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEURONOX

ST13

US500000098155440

Class

5

Filing

98155440

Registration

7486245

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

08/27/2024

Trademark type

Word

Nice classes

5

Filing date

08/29/2023

Registration date

08/27/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/27/2024

Last transaction

08/27/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Chungcheongbuk-do, KR

Examiner

BEAUDRY-TORRES, FAITH

Law office

N80

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Medytox Inc.

Representatives

MARK J. LISS LEYDIG, VOIT & MAYER, LTD.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Analgesics; Appetite suppressants for medical purposes; Pharmaceutical preparations acting on the central nervous system; Vaccines; Muscle relaxants; Injectable dermal filler for medical purpose; Pharmaceutical agents for epidermis; Pharmaceutical preparations for skin care; Antibiotic preparations; Bacterial poisons; Pharmaceutical agents affecting peripheral nervous systemcentral nervous system stimulantsnasal and oral spray preparations for use as central nervous system stimulantspharmaceutical preparations acting on the central nervous system; Dermatological pharmaceutical products; Pharmaceutical preparations for treating skin disorders; Analgesic and muscle relaxant pharmaceutical preparations; Medicated lotions for skinhairsunburnfacebody; Pharmaceutical ointmentsantibiotic ointmentsanti-inflammatory ointmentsanti-itch ointmenthemorrhoidal ointments; Hemorrhoid treatment preparations

Publications

History of USPTO decisions and trademark events.

13 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/27/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/27/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/11/2024

PUBO

PUBLISHED FOR OPPOSITION

06/11/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/22/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/08/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

05/08/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/08/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

05/08/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/08/2024

DOCK

ASSIGNED TO EXAMINER

04/26/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/26/2023

NWAP

NEW APPLICATION ENTERED

09/01/2023

Continuous trademark protection

Get notified about every new filing that threatens NEURONOX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.